Difference between revisions of "Key molecular pathways in ALS"

From MyWiki
Jump to: navigation, search
Line 1: Line 1:
{| class="wikitable"
+
{̺{tip|For very comprehensive pathway diagrams for LMN ALS see, https://files.acrobat.com/a/preview/646bf152-9ef2-4f51-8d4a-cb8e9fc0a4ac}}
 +
}| class="wikitable"
 
! Pathway || Type || Activated by || Inhibited by || Activates || Inhibits
 
! Pathway || Type || Activated by || Inhibited by || Activates || Inhibits
 
|-
 
|-
Line 17: Line 18:
 
|-
 
|-
 
| VEGF
 
| VEGF
+
 
For very comprehensive pathway diagrams for LMN ALS see, https://files.acrobat.com/a/preview/646bf152-9ef2-4f51-8d4a-cb8e9fc0a4ac
 
 
|}
 
|}

Revision as of 09:36, 28 February 2018

{̺{tip|For very comprehensive pathway diagrams for LMN ALS see, https://files.acrobat.com/a/preview/646bf152-9ef2-4f51-8d4a-cb8e9fc0a4ac}} }| class="wikitable" ! Pathway || Type || Activated by || Inhibited by || Activates || Inhibits |- | NF-kappaB || Inflammatory |- | TNF-alpha |- | caspase-3 |- | AMPK-α1 |- | IL-10 |- | SARM1 |- | PKC |- | VEGF

|}